CT seeks THC caps on unregulated marijuana products, synthetics ban

Connecticut legislators took the first step toward outlawing synthetic marijuana and imposing THC caps on sleep aids and other consumable products sold in convenience and CBD stores outside the state’s regulated medical and recreational cannabis markets.

Synthetic cannabinoids further rift between marijuana and hemp industries

A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and Delta-lineage products since the passage of the 2018 Farm Bill.

Synthetic cannabinoid maker Nalu Bio raises $12 million

Nalu Bio, a producer of synthetic cannabinoids, said it raised $12 million in a Series A funding round led by Intrinsic Capital Partners, a Pennsylvania-based investment firm focused on life science and technology businesses in the legal marijuana and hemp industries.

Utah to seek curbs on delta-8 THC, other synthetics in medical marijuana market

Utah regulators say they’re pushing for new rules governing the presence of delta-8 THC and other synthetic cannabinoids allowed in the state’s medical marijuana supply.

Synthetic CBD might offer protection from COVID-19, Canadian research shows

More research saying cannabinoids might protect human cells from COVID-19 was released this week by scientists in Ontario, Canada, who work with synthetic CBD.

How to decide on synthetic versus organic fertilizers for cannabis plant nutrition

Cannabis is a heavy-feed crop, requiring plenty of nutrition to produce high yields.

Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD

A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a 64% increase in death in older patients with chronic obstructive pulmonary disease (COPD). These oral drugs—nabilone and dronabinol—have a chemical structure similar to THC and are often prescribed to treat symptoms associated with COPD, including pain, sleep difficulties and breathlessness.

Sanobiotec produces pure, stable synthetic THCV

Contributing to a growing list of synthetically produced cannabis compounds, Sanobiotec announced the synthesis of pure and stable Tetrahydrocannabivarin (THCV).

Synthetic cannabinoid partnership devolves into $881 million lawsuit

A cannabis research and development deal hailed just last March as a $300 million partnership has morphed into a nearly $1 billion court battle.

Demetrix raises $50 million to research synthetic cannabinoid production

California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production.